Cargando…

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection

BACKGROUND: V-set and immunoglobulin domain containing protein 4 (VSIG4) was reported to play an important role in tumorigenesis. However, the expression and clinical relevance in hepatocellular carcinoma (HCC) remain unknown. MATERIALS AND METHODS: First, the mRNA profiles of HCC were screened from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Sicong, Tan, Wenliang, Li, Wenxin, Zhou, Rui, Wu, Xiaolin, Chen, Xianqing, Li, Wenda, Shang, Changzhen, Chen, Yajin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159793/ https://www.ncbi.nlm.nih.gov/pubmed/30288101 http://dx.doi.org/10.2147/CMAR.S165822

Ejemplares similares

miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
por: Chen, Xianqing, et al.
Publicado: (2019)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2018)

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhu, Sicong, et al.
Publicado: (2019)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
por: Tan, Wenliang, et al.
Publicado: (2021)

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
por: Tan, Wenliang, et al.
Publicado: (2017)

A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma
por: Chen, Jie, et al.
Publicado: (2020)

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway
por: Yang, Lei, et al.
Publicado: (2022)

VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding
por: Ebstein, Sarah Y, et al.
Publicado: (2023)

Structural Basis of VSIG3: The Ligand for VISTA
por: Xie, Xiaoxue, et al.
Publicado: (2021)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
por: Li, Jialin, et al.
Publicado: (2017)

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
por: Han, Sang Youb, et al.
Publicado: (2022)

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages
por: Huang, Xiaoyong, et al.
Publicado: (2019)

Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells
por: Huang, Zejian, et al.
Publicado: (2017)

Adhesion Protein VSIG1 Is Required for the Proper Differentiation of Glandular Gastric Epithelia
por: Oidovsambuu, Odgerel, et al.
Publicado: (2011)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)

Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue
por: Hall, Brandon M., et al.
Publicado: (2020)

Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma
por: Yang, Chen, et al.
Publicado: (2019)

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy
por: Zhou, Xia, et al.
Publicado: (2022)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

VSIG4 overexpression alleviates acute kidney injury of mice via inhibition of M1-macrophages activation
por: Li, Yan, et al.
Publicado: (2022)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
por: Zheng, Congying, et al.
Publicado: (2023)

Hypoxia Induces M2 Macrophages to Express VSIG4 and Mediate Cardiac Fibrosis After Myocardial Infarction
por: Wang, Yan, et al.
Publicado: (2023)

Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma
por: Ruan, Haoyu, et al.
Publicado: (2016)

Key Candidate Genes – VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis
por: Cui, Zhongze, et al.
Publicado: (2021)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

High expression of lncRNA-SNHG7 is associated with poor prognosis in hepatocellular carcinoma
por: Shen, An, et al.
Publicado: (2020)

Localization of the Novel Hair Shaft Protein VSIG8 in the Hair Follicle, Nail Unit and Oral Cavity
por: Rice, Robert H., et al.
Publicado: (2011)

VSIG4 Induces Epithelial-Mesenchymal Transition of Renal Tubular Cells under High-Glucose Conditions
por: Gong, Eun-Yeung, et al.
Publicado: (2020)

Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
por: Reißing, Johanna, et al.
Publicado: (2021)

Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2016)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gf7er3to2030feamif1gkjqv71